山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (8): 116-121.doi: 10.6040/j.issn.1671-7554.0.2023.0238
• 病例报道 • 上一篇
王璐瑶1,2,李建婷1,姚静1,董振华1,逄曙光1,2
中图分类号:
| [1] Maher ER, Iselius L, Yates JR, et al. Von Hippel-Lindau disease: a genetic study[J]. J Med Genet,1991, 28(7):443-447. [2] Chittiboina P, Lonser RR. Von Hippel-Lindau disease[J]. Handb Clin Neurol, 2015, 132:139-156. doi:10.1016/b978-0-444-62702-5.00010-x. [3] Hong B, Ma K, Zhou J, et al. Frequent mutations of VHL gene and the clinical phenotypes in the largest Chinese cohort with von hippel-lindau disease[J]. Front Genet, 2019, 10:867. doi:10.3389/fgene.2019.00867. [4] Vibert R, Lahlou-Laforêt K, Samadi M, et al. Minors at risk of von Hippel-Lindau disease: 10 years experience of predictive genetic testing and follow-up adherence[J]. Eur J Hum Genet, 2022, 30(10):1171-1177. [5] Aronow ME, Wiley HE, Gaudric A, et al. Von Hippel-Lindau Disease: update on pathogenesis and systemic aspects[J]. Retina, 2019, 39(12):2243-2253. [6] Tarade D, Ohh M. The HIF and other quandaries in VHL disease[J]. Oncogene, 2017, 37(2):139-147. [7] Lonser RR, Glenn GM, Walther M, et al. Von hippel-lindau disease[J]. Lancet, 2003, 361(9374):2059-2067. [8] Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment[J]. Curr Probl Cancer, 2014, 38(1):7-41. [9] Lomte N, Kumar S, Sarathi V, et al. Genotype phenotype correlation in Asian Indian von Hippel-Lindau(VHL)syndrome patients with pheochromocytoma/paraganglioma[J]. Fam Cancer, 2018, 17(3):441-449. [10] Sheikhi V, Heidari Z. Increase in thyrotropin is associated with an increase in serum prolactin in euthyroid subjects and patients with subclinical hypothyroidism[J]. Med J Islam Repub Iran, 2021, 35:167. doi:10.47176/mjiri.35.167. [11] Sharma LK, Sharma N, Gadpayle AK, et al. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism[J]. Eur J intern Med, 2016, 35:106-110. doi:10.1016/j.ejim.2016.07.012. [12] Bahar A, Akha O, Kashi Z, et al. Hyperprolactinemia in association with subclinical hypothyroidism[J]. Caspian J intern Med, 2011, 2(2):229-233. [13] Arao T, Okada Y, Tanikawa T, et al. A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism[J]. Endocr J, 2002, 49(2):181-188. [14] Mittal M, Gupta P, Chaudhary GR,et al. Hypercalcemia in pheochromocytoma: from MEN to VHL[J]. J Endocrine Soc, 2021, 5(Suppl 1): 997-998. [15] Belaid R, Oueslati I, Chihaoui M, et al. A case of von hippel-lindau disease with bilateral pheochromocytoma and ectopic hypersecretion of intact parathyroid hormone in an adolescent girl[J]. Case Rep Endocrinol, 2020, 2020:8824640. doi:10.1155/2020/8824640. [16] Ronen JA, Gavin M, Ruppert MD, et al. Glycemic disturbances in pheochromocytoma and paraganglioma[J]. Cureus, 2019, 11(4):e4551. [17] Louise M Binderup M, Smerdel M, Borgwadt L, et al. Von Hippel-Lindau disease: updated guideline for diagnosis and surveillance[J]. Eur J Med Genet, 2022, 65(8):104538. [18] Ahmad S, Naber MR, Giles RH, et al. Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic review[J]. Endocr Relat Cancer, 2021, 28(3):151-160. [19] Krauss T, Ferrara AM, Links TP, et al. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors[J]. Endocr Relat Cancer, 2018, 25(9): 783-793. |
| [1] | 于书卷,王美娟,陈丽,曹英娟,吕晓燕,刘雪燕,林鹏,颜景政. 老年2型糖尿病患者轻度认知功能障碍的影响因素[J]. 山东大学学报 (医学版), 2022, 60(11): 108-112. |
| [2] | 吕丽,姜璐,陈诗鸿,庄向华,宋玉文,王殿辉,安文娟,李倩,潘喆. 210例绝经后2型糖尿病发生骨质疏松的相关因素[J]. 山东大学学报 (医学版), 2021, 59(7): 19-25. |
| [3] | 李涵,付婷婷,张磊,延冰,孙涛,郭峰,尹晓. 过氧化物酶增殖物激活受体γ激动剂对24例肥胖症患者米色脂肪细胞分化的影响[J]. 山东大学学报 (医学版), 2020, 1(9): 8-13. |
| [4] | 扈艳雯,王志媛,郁万江,赵蕙琛,韩合理,徐志鹏,马红,张玉超,刘元涛. 52例肥胖患者脂肪分布与代谢综合征及糖代谢指标的相关性[J]. 山东大学学报 (医学版), 2020, 1(8): 101-106. |
| [5] | 丁华琳,李扬扬,于丰源,战伟伟,于苏国. 达格列净通过Klotho/TGF-β1通路抑制糖尿病肾病大鼠肾纤维化的作用[J]. 山东大学学报 (医学版), 2020, 58(3): 75-80. |
| [6] | 唐博,邵静,崔静,孙健平. 2型糖尿病发病与高密度脂蛋白关系的机制研究[J]. 山东大学学报 (医学版), 2020, 58(3): 99-106. |
| [7] | 王敏,王春花,刘鸿丽,何志良,崔薇薇,王磊,刘杰军. 男性儿童瘦素抵抗对成年后健康状况的影响[J]. 山东大学学报 (医学版), 2018, 56(10): 114-118. |
| [8] | 李洪志,申永超,刘洁婷,赵孝金,初彦辉,袁晓环. 11β-HSD1抑制剂改善db/db小鼠胰岛素敏感性的实验研究[J]. 山东大学学报（医学版）, 2017, 55(10): 59-64. |
| [9] | 巩璐伟,周丽珍,苏国海. 培哚普利通过调节Akt-FoxO1通路保护糖尿病性心肌病大鼠心功能损伤[J]. 山东大学学报（医学版）, 2017, 55(10): 65-70. |
| [10] | 刘贺,刘福强,侯新国,陈丽. CYP11B1基因新突变致11β-羟化酶缺陷症1例家系研究[J]. 山东大学学报（医学版）, 2017, 55(9): 85-89. |
| [11] | 刘攀,何天祎,赵汝星,孙宇,陈丽. 百令胶囊对Graves病患者自身免疫的调理作用[J]. 山东大学学报（医学版）, 2017, 55(9): 90-95. |
| [12] | 姬原原,包景泊,赵旭,曹鲁宁,崔敏,张娜,于灵芝. 白介素17F促进大鼠成骨细胞增殖、矿化和Runx2、Osterix的表达[J]. 山东大学学报（医学版）, 2017, 55(8): 24-29. |
| [13] | 张亮,徐敏,庄向华,娄福臣,娄能俊,吕丽,郭文娟,郑凤杰,陈诗鸿. 内质网应激与凋亡在糖尿病周围神经病变中的表达变化[J]. 山东大学学报（医学版）, 2017, 55(8): 13-17. |
| [14] | 曹瑾,季晓康,孙秀彬,蒋正,薛付忠. γ-谷氨酰转肽酶与高尿酸血症关系的队列分析[J]. 山东大学学报（医学版）, 2017, 55(6): 124-128. |
| [15] | 张光,王广银,吴红彦, 张红玉,王停停,李吉庆,李敏,康凤玲,刘言训,薛付忠. 健康管理人群高脂血症风险预测模型[J]. 山东大学学报（医学版）, 2017, 55(6): 72-76. |
|
||
